Tuesday, September 16, 2014 11:43:35 AM
True but irrelevant. Hensley didn't make errors in production- he tried to sell an unapproved drug - a uselsss one at that - for a very serious disease. That's a scam. Frankly he's very lucky he didn't get put away.
"LOS ANGELES (CBS) — The man who invented Zicam was sentenced Thursday to three years of probation for illegally marketing an unapproved drug he claimed could prevent and treat bird flu.
Charles B. Hensley, 58, of Redondo Beach, was indicted last year on a dozen felony charges related to sales of an influenza-treatment product called Vira 38 that did not have U.S. Food and Drug Administration approval.
As part of an agreement with prosecutors, Hensley pleaded guilty to one of the charges, Assistant U.S. Attorney Pio S. Kim said.
Hensley was ordered to serve 400 hours of community service and pay a $5,000 fine, Kim said.
Hensley was arrested last June by members of the Southern California Import Task Force, which consists of FDA and United States Postal Service agents and Los Angeles Police investigators.
Prosecutors say Hensley operated PRB Pharmaceuticals Inc., which marketed Vira 38 as an influenza medication in Hong Kong.
When marketing efforts failed, in part because of the lack of clinical data demonstrating the product’s usefulness, Hensley promoted Vira 38 as a medication to fight the H5N1 virus, which causes bird flu, according to the indictment.
While Hensley touted Vira 38 as a cure for bird flu, the product had not been approved by the FDA, according to the U.S. Attorney’s Office."
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
"Nobody ever went broke underestimating the intelligence of the American public."
H. L. Mencken
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM